- Home
- KOSS vs GNTA Comparison
KOSS vs GNTA Comparison
Compare KOSS & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOSS | GNTA |
|---|---|---|
| Founded | 1953 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.6M | 39.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | KOSS | GNTA |
|---|---|---|
| Price | $4.85 | $1.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.6K | ★ 122.3K |
| Earning Date | 10-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,493,080.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.58 | N/A |
| 52 Week Low | $4.00 | $1.35 |
| 52 Week High | $8.59 | $10.00 |
Technical Indicators
Market Signals| Indicator | KOSS | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 40.48 |
| Support Level | $4.81 | $1.80 |
| Resistance Level | $4.99 | $2.20 |
| Average True Range (ATR) | 0.19 | 0.23 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 71.43 | 59.66 |
Price Performance
Historical ComparisonAbout KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.